Unity Biotechnology Inc (UBX)

NASDAQ
0.395
-0.019(-4.68%)
  • Volume:
    530,186
  • Day's Range:
    0.395 - 0.410
  • 52 wk Range:
    0.382 - 3.640

UBX Overview

Prev. Close
0.415
Day's Range
0.395-0.41
Revenue
5.02M
Open
0.41
52 wk Range
0.382-3.64
EPS
-0.943
Volume
530,186
Market Cap
55.53M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,817,319
P/E Ratio
-0.546
Beta
0.721
1-Year Change
-85.08%
Shares Outstanding
140,226,122
Next Earnings Date
Nov 09, 2022
What is your sentiment on Unity Biotech?
or
Vote to see community's results!

Unity Biotechnology Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Unity Biotechnology Inc Analysis

Unity Biotechnology Inc Company Profile

Unity Biotechnology Inc Company Profile

Employees
65

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company’s lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Read More

Analyst Price Target

Average6.000 (+1418.99% Upside)
High12
Low3
Price0.395
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • I will buy this for my grandchildren!
    0
    • 100 DOLARLIK al bekle 3 gune satarsin!
      0
    • Do you think is good this stock and also good make money,please let me know if this good for the future and maybe i will buy too thanks
      0
  • If bezos and thiel are in, im in
    0
    • now my sweet Yuliya what please ? pozalusta ? to entry inside you or not to entry ? best regars., Panagiotakis to kalo paidi.!
      0
    • to entry in Unity or not to entry what do you think ? best regards., Panagiotakis.
      1
  • 15% up?
    0
    • I would be too beautiful if their drug candidates worked. Unfortunately, the data says otherwise. They still have a few in the pipeline, and some cash to burn. Eventually they will have to issue more shares or issue large debts (Powell to buy?).. So, expect 1-5$ range for a while.
      0
      • bad stock no future.😢😢
        2
        • never...
          0
          • will this go back up
            0
            • bear very fear
              0
              • https://www.globenewswire.com/news-release/2020/08/17/2079116/0/en/UNITY-Biotechnology-Announces-12-week-data-from-UBX0101-Phase-2-Clinical-Study-in-Patients-with-Painful-Osteoarthritis-of-the-Knee.html
                2
                • is it true that Jeff Bezos from Amanon  invested 300mln USD in this company ?
                  0
                  • tom abchttps://www.cnbc.com/2018/08/29/jeff-bezos-backs-silicon-valley-scientist-working-on-a-cure-for-aging.html
                    0
                  • Ralph Lynchis it worth to entry for short or for mid - long term period ?
                    0
                  • tom abcis it worth to entry in this equity for short or for mid long term please ?
                    0